Paperpal Prime Logo

European urology oncology : Impact Factor & More

eISSN: 2588-9311pISSN: 2588-9311

Aims and Scope of European urology oncology

European Urology Oncology is the new sister journal to European Urology and European Urology Focus, and the first official publication of the EAU fully devoted to the study of genitourinary malignancies. Less

Key Metrics

CiteScore
9.4
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Surgery
SNIP
2.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European urology oncology

European urology oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2018
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European urology oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European urology oncology

Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival.
  • 31 Jan 2027
  • European urology oncology
Reducing MRI Use in Organized Prostate Cancer Testing Using Blood-based Biomarkers: The OPT Stockholm3 Study.
  • 7 Aug 2026
  • European urology oncology
Detection and Localization of Unfavorable-histology Prostate Cancer Using MRI and Whole-mount Histopathology.
  • 7 Aug 2026
  • European urology oncology
NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol.
  • 7 Aug 2026
  • European urology oncology
Prognostic Factors After Radical Cystectomy for Non-muscle-invasive Bladder Cancer: From Prognostication to Patient Selection.
  • 7 Aug 2026
  • European urology oncology
Validation of an AI-based Histologic Prognostic Biomarker in Patients with Non-muscle-invasive Bladder Cancer Using the Prospective Swedish National Register of Urinary Bladder Cancer.
  • 4 Aug 2026
  • European urology oncology
Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival.
  • 31 Jan 2027
  • European urology oncology
Reducing MRI Use in Organized Prostate Cancer Testing Using Blood-based Biomarkers: The OPT Stockholm3 Study.
  • 7 Aug 2026
  • European urology oncology
Detection and Localization of Unfavorable-histology Prostate Cancer Using MRI and Whole-mount Histopathology.
  • 7 Aug 2026
  • European urology oncology
NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol.
  • 7 Aug 2026
  • European urology oncology
Prognostic Factors After Radical Cystectomy for Non-muscle-invasive Bladder Cancer: From Prognostication to Patient Selection.
  • 7 Aug 2026
  • European urology oncology
Validation of an AI-based Histologic Prognostic Biomarker in Patients with Non-muscle-invasive Bladder Cancer Using the Prospective Swedish National Register of Urinary Bladder Cancer.
  • 4 Aug 2026
  • European urology oncology

FAQs on European urology oncology